Compounds > triazoles
Page last updated: 2024-08-24

triazoles and dactolisib

triazoles has been researched along with dactolisib in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's5 (62.50)24.3611
2020's3 (37.50)2.80

Authors

AuthorsStudies
Airoud, K; Alfieri, RR; Andreis, D; Bertoni, R; Bonelli, MA; Bottini, A; Cavazzoni, A; Fumarola, C; Galetti, M; Galvani, E; Generali, D; Harris, AL; La Monica, S; Martin, LA; Petronini, PG; Tramonti, S1
Acquaviva, J; Friedland, JC; He, S; Proia, DA; Sang, J; Sequeira, M; Smith, DL; Wada, Y; Zhang, C1
Ito, TK; Kadariya, Y; Pei, J; Sementino, E; Tan, Y; Testa, JR1
Akudugu, JM; Hamunyela, RH; Serafin, AM1
Bruckman, RS; Campbell, GR; Durden, DL; Herns, SD; Joshi, S; Spector, SA1
Band, H; Chaturvedi, NK; Coulter, DW; Griggs, CN; Joshi, SS; Kesherwani, V; Kling, MJ; Liu, Y; McGuire, TR; McIntyre, EM; Ray, S; Sharp, JG; Shukla, M1
Cho, KH; Lee, HS; Lee, S1
Gong, W; Jiang, Y; Kong, D; Liu, C; Miao, X; Tian, R; Wang, X; Wang, Y; Wu, Z; Yu, X; Zhu, X1

Other Studies

8 other study(ies) available for triazoles and dactolisib

ArticleYear
Overcoming acquired resistance to letrozole by targeting the PI3K/AKT/mTOR pathway in breast cancer cell clones.
    Cancer letters, 2012, Oct-01, Volume: 323, Issue:1

    Topics: Aged; Antineoplastic Agents; Blotting, Western; Breast Neoplasms; Cell Line, Tumor; Drug Resistance, Neoplasm; Everolimus; Female; Humans; Imidazoles; Immunosuppressive Agents; Letrozole; Neoadjuvant Therapy; Nitriles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Quinolines; Signal Transduction; Sirolimus; TOR Serine-Threonine Kinases; Triazoles

2012
Targeting KRAS-mutant non-small cell lung cancer with the Hsp90 inhibitor ganetespib.
    Molecular cancer therapeutics, 2012, Volume: 11, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Benzimidazoles; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Female; Genes, ras; Humans; Imidazoles; Lung Neoplasms; Mice; Mice, Nude; Mutation; Phosphoinositide-3 Kinase Inhibitors; Quinolines; Signal Transduction; TOR Serine-Threonine Kinases; Triazoles; Xenograft Model Antitumor Assays

2012
Co-targeting of Akt and Myc inhibits viability of lymphoma cells from Lck-Dlx5 mice.
    Cancer biology & therapy, 2015, Volume: 16, Issue:4

    Topics: Animals; Apoptosis; Azepines; Cell Cycle Checkpoints; Cell Line, Tumor; Cell Proliferation; Cell Survival; Everolimus; Homeodomain Proteins; Imidazoles; Lymphocyte Specific Protein Tyrosine Kinase p56(lck); Mice; Precursor T-Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogene Proteins c-akt; Proto-Oncogene Proteins c-myc; Quinolines; Signal Transduction; Thiazoles; Transcription, Genetic; Triazoles; Vincristine

2015
Strong synergism between small molecule inhibitors of HER2, PI3K, mTOR and Bcl-2 in human breast cancer cells.
    Toxicology in vitro : an international journal published in association with BIBRA, 2017, Volume: 38

    Topics: Aniline Compounds; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Line, Tumor; Cell Survival; Drug Synergism; Humans; Imidazoles; Oxazoles; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Proto-Oncogene Proteins c-bcl-2; Quinolines; Receptor, ErbB-2; Sulfonamides; TOR Serine-Threonine Kinases; Triazoles

2017
Induction of autophagy by PI3K/MTOR and PI3K/MTOR/BRD4 inhibitors suppresses HIV-1 replication.
    The Journal of biological chemistry, 2018, 04-20, Volume: 293, Issue:16

    Topics: Anti-HIV Agents; Autophagy; Azepines; Cell Cycle Proteins; Cells, Cultured; HIV Infections; HIV-1; Humans; Imidazoles; Macrophages; Nuclear Proteins; Phosphatidylinositol 3-Kinase; Phosphoinositide-3 Kinase Inhibitors; Protein Kinase Inhibitors; Quinolines; Signal Transduction; TOR Serine-Threonine Kinases; Transcription Factors; Triazoles; Virus Replication

2018
A Novel Combination Approach Targeting an Enhanced Protein Synthesis Pathway in MYC-driven (Group 3) Medulloblastoma.
    Molecular cancer therapeutics, 2020, Volume: 19, Issue:6

    Topics: Animals; Antineoplastic Agents; Apoptosis; Azepines; Cell Cycle; Cell Proliferation; Cerebellar Neoplasms; Female; Gene Expression Regulation, Neoplastic; Humans; Imidazoles; Medulloblastoma; Mice; Mice, Inbred NOD; Mice, SCID; Protein Biosynthesis; Proto-Oncogene Proteins c-myc; Quinolines; TOR Serine-Threonine Kinases; Triazoles; Tumor Cells, Cultured; Xenograft Model Antitumor Assays

2020
Cotargeting BET proteins overcomes resistance arising from PI3K/mTOR blockade-induced protumorigenic senescence in colorectal cancer.
    International journal of cancer, 2020, 11-15, Volume: 147, Issue:10

    Topics: Animals; Azepines; Caco-2 Cells; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Colorectal Neoplasms; Drug Resistance, Neoplasm; Drug Synergism; Gene Expression Regulation, Neoplastic; HCT116 Cells; Humans; Imidazoles; Mice; p38 Mitogen-Activated Protein Kinases; Phosphatidylinositol 3-Kinase; Phosphorylation; Proteomics; Quinolines; Signal Transduction; TOR Serine-Threonine Kinases; Triazoles; Xenograft Model Antitumor Assays

2020
BET protein inhibition evidently enhances sensitivity to PI3K/mTOR dual inhibition in intrahepatic cholangiocarcinoma.
    Cell death & disease, 2021, 10-29, Volume: 12, Issue:11

    Topics: Animals; Antineoplastic Agents; Azepines; Bile Duct Neoplasms; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cholangiocarcinoma; Disease Models, Animal; Drug Therapy, Combination; Humans; Imidazoles; Mice; MTOR Inhibitors; Nerve Tissue Proteins; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Quinolines; Receptors, Cell Surface; Signal Transduction; TOR Serine-Threonine Kinases; Transcriptome; Treatment Outcome; Triazoles

2021